Cancer: Medical Treatments
Commons · Question 66392 · Tabled 9 Jul 2025 · Department of Health and Social Care · Official record
Answered 15 Jul 2025
Question
Asked by Clive Jones
To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) representatives of the pharmaceutical industry, (b) the NHS, (c) Cabinet colleagues and (d) other stakeholders on indication-specific pricing of medications use
Answer
Answered by Karin Smyth, 15 Jul 2025
My Rt Hon. Friend, the Secretary of State for Health and Social Care has not held any meetings specifically on the topic of indication-specific pricing of medications used in the treatment of more than one form of cancer.